In 2024, Remipharma MB had revenue of 57.6 thousand EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 57,6k € +0.9% | 57,1k € +487.5% | 9,7k € |
Profit | - | - | - |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - |
Employees | - | - | - |
Overall rating | B70/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 70/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Male) |
Remipharma MB is located at Vilnius, M. Mažvydo g. 17-30, LT-06256, LT-LT-06256.
The shareholders of Remipharma MB include 1 Lithuanian legal entities. View ownership details →
Yes, Remipharma MB is registered as an active VAT payer with VAT number LT100018939710.
Remipharma MB was founded on September 12, 2022. The company has been operating for 4 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 4 years | 1033 - 1037 | 34% | |
Net revenue | 57 620,00 € | 683 - 687 | 56% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Registered in the Lithuanian register of legal entities.